公开(公告)号：WO2008007930A1

公开(公告)日：2008-01-17

申请号：PCT/KR2007003429

申请日：2007-07-13

Applicant: LG LIFE SCIENCES LTD ,  CHOI SUNG PIL ,  AHN IN AE ,  LEE SANG HYUP ,  LEE SANG DAE ,  SHIN MI SOOK ,  LEE KOO ,  CHOI DEOG YOUNG ,  SHIM DONG SUP ,  YIM HYEON JOO ,  YOON MIN KYUNG ,  CHUNG SOO YONG ,  LEE JUNG AE ,  HA YONG HWA ,  KIM YOUNG KWAN ,  PARK OEUK ,  LEE HYUN MIN ,  KIM YOUN HOA

Inventor： CHOI SUNG PIL ,  AHN IN AE ,  LEE SANG HYUP ,  LEE SANG DAE ,  SHIN MI SOOK ,  LEE KOO ,  CHOI DEOG YOUNG ,  SHIM DONG SUP ,  YIM HYEON JOO ,  YOON MIN KYUNG ,  CHUNG SOO YONG ,  LEE JUNG AE ,  HA YONG HWA ,  KIM YOUNG KWAN ,  PARK OEUK ,  LEE HYUN MIN ,  KIM YOUN HOA

IPC: C07D403/06

CPC classification number: C07D207/16 ,  C07D207/48 ,  C07D401/14 ,  C07D405/14 ,  C07D409/14 ,  C07D413/14 ,  C07D417/14

Abstract: The present invention relates to a compound of the following formula 1, pharmaceutically acceptable salt and isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.

Abstract translation: 本发明涉及有效作为黑皮质素受体激动剂的下式1化合物，其药学上可接受的盐和异构体，以及包含与活性成分相同的黑皮质素受体激动剂组合物。

公开(公告)号：WO2008007930A9

公开(公告)日：2008-01-17

申请号：PCT/KR2007/003429

申请日：2007-07-13

Applicant: LG LIFE SCIENCES LTD. ,  CHOI, Sung Pil ,  AHN, In Ae ,  LEE, Sang Hyup ,  LEE, Sang Dae ,  SHIN, Mi Sook ,  LEE, Koo ,  CHOI, Deog Young ,  SHIM, Dong Sup ,  YIM, Hyeon Joo ,  YOON, Min Kyung ,  CHUNG, Soo Yong ,  LEE, Jung Ae ,  HA, Yong Hwa ,  KIM, Young Kwan ,  PARK, Oeuk ,  LEE, Hyun Min ,  KIM, Youn Hoa

Inventor： CHOI, Sung Pil ,  AHN, In Ae ,  LEE, Sang Hyup ,  LEE, Sang Dae ,  SHIN, Mi Sook ,  LEE, Koo ,  CHOI, Deog Young ,  SHIM, Dong Sup ,  YIM, Hyeon Joo ,  YOON, Min Kyung ,  CHUNG, Soo Yong ,  LEE, Jung Ae ,  HA, Yong Hwa ,  KIM, Young Kwan ,  PARK, Oeuk ,  LEE, Hyun Min ,  KIM, Youn Hoa

IPC: C07D403/06

Abstract: The present invention relates to a compound of the following formula 1, pharmaceutically acceptable salt and isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.